(Q71479427)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6761818%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

title

[Medium term effect (3 months) of hypoglycemic sulfamide treatment (gliclazide) on insulin secretion of the non-insulin dependent diabetic] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6761818%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

J M Brogard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6761818%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

M Pinget

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6761818%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

A Leconte

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6761818%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

M Dorner

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6761818%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

publication date

1 December 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6761818%20AND%20SRC:MED&resulttype=core&format=json

Revue de Médecine Interne

18 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6761818%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6761818%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6761818%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

379-387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6761818%20AND%20SRC:MED&resulttype=core&format=json

Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects

18 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2882%2980048-9

7 January 2021

Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2882%2980048-9

7 January 2021

On the pathogenesis of maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2882%2980048-9

7 January 2021

Quantitative and qualitative changes in the early insulin response to glucose in subjects with impaired carbohydrate tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2882%2980048-9

7 January 2021

10.1016/S0248-8663(82)80048-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6761818%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference